During the next decade, the clinical chemistry market will undergo significant transformation. The changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments like routine chemistry will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.

The Clinical Chemistry Market: US, Europe, Japan is a unique worldwide market and technology assessment designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores the future trends in the U.S., five major European countries, and Japan; provides estimates of the test and sales volumes, as well as major suppliers sales and market shares; compares features of leading analyzers; and profiles key competitors.

Contains 520 pages and 195 tables

Click for Report details:The 2012 Clinical Chemistry Market: US, Europe, Japan